Exclusive news and analysis of the rapidly evolving ETF landscape, built for advisors and capital allocators.
Providers are targeting AI-adjacent companies abroad in pursuit of returns, with some leaving US firms behind altogether.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Boring won. On the 50th anniversary of the index fund, a look at how “Bogle’s Folly” became the dominant force in American investing.
Some custodians are charging issuers for shelf space, but Vanguard could challenge that practice.
Equal-weighted index funds are surging amid concerns of a tech bubble.
Investors are moving into agriculture funds as tight fertilizer supply and bad weather forecasts squeeze crop yields.
Thirty-year US Treasury yields have reached their highest levels in almost 20 years amid a massive selloff.
More than a few companies include “shares” in ETF product titles, and Northern Trust is among a few that have changed course.
The acquisition would more than double the firm’s fixed income ETF assets.
A recent study found that the popularity of low-cost, passive index funds may be hampering returns for active products.
Dual-share-class product development has initially been slow, but more companies are rolling out funds or merging them.
It’s the first attempt in the industry to fit something akin to sports betting into an exchange-traded fund wrapper.
The big three issuers still have a massive lead, but more newcomers are demanding attention.
The surge in new products has advisors questioning whether the market is evolving or simply overcrowded.
Ai Funds launched an ETF that uses a proprietary AI model to pick stocks and adjust risk.
The three firms now manage 52% of assets among the largest 150 fund companies, up from 43% a decade ago.
Research Affiliates, which recently sold its RAFI Indices business to TMX, just had a major brand overhaul.
Conversion, rather than adding a dual share class, offers ETFs an existing asset base and track record.
While the AI company’s IPO could be record-breaking, SpaceX’s rocky landing earlier reminds investors to “know what the heck you’re buying.”
A letter filed in response to the SEC’s request for comment on “novel ETFs” calls for rethinking the product’s naming conventions.
While issuers have been told by the SEC to hold their plans for new 3x, 4x and 5x funds, Defiance recently filed for a series of 2x funds that would reset hourly.
The State Street SPDR S&P Biotech ETF is up 33% this year, but fund flows remain muted.